Buscar

13/10/2023 Are all JAK inhibitors for the treatment of rheumatoid arthritis equivalent? An adjusted indirect comparison of the efficacy of tofacitinib, baricitinib, upadacitinib, and filgotinib
Vallez-Valero L., Gasó-Gago I., Marcos-Fendian Á., Garrido-Alejos G., Riera-Magallón A., Plaza Diaz A., Martinez-Molina C., Mangues-Bafalluy M.A., Corominas H.. Are all JAK inhibitors for the treatment of rheumatoid arthritis equivalent? An adjusted indirect comparison of the efficacy of tofacitinib, baricitinib, upadacitinib, and filgotinib. CLINICAL RHEUMATOLOGY. 2023; 42(12)DOI:10.1007/s10067-023-06787-2. PMID:37831336. IF:2.900(Q2/4D).
01/10/2023 Implementation and operational management of marketed chimeric antigen receptor T cell (CAR-T Cell) therapy-a guidance by the GoCART Coalition Pharmacist Working Group
Nezvalova-Henriksen K., Langebrake C., Bauters T., Moreno-Martinez M.-E., Ahnfelt E., Ekelund H., Domingos V., Pires V., Bonnin A., Bojanic I., Cabrerizo Y., Terwel S., Tam A.. Implementation and operational management of marketed chimeric antigen receptor T cell (CAR-T Cell) therapy-a guidance by the GoCART Coalition Pharmacist Working Group. BONE MARROW TRANSPLANTATION. 2023; 58(10)DOI:10.1038/s41409-023-02072-7. PMID:37528237. IF:4.500(Q1/2D).
01/10/2023 GEMA 5.3. Spanish Guideline on the Management of Asthma
Plaza Moral V., Alobid I., Álvarez Rodríguez C., Blanco Aparicio M., Ferreira J., García G., Gómez-Outes A., Garín Escrivá N., Gómez Ruiz F., Hidalgo Requena A., Korta Murua J., Molina París J., Pellegrini Belinchón F.J., Plaza Zamora J., Praena Crespo M., Quirce Gancedo S., Sanz Ortega J., Soto Campos J.G.. GEMA 5.3. Spanish Guideline on the Management of Asthma. Open Respiratory Archives. 2023; 5(4)DOI:10.1016/j.opresp.2023.100277. PMID:37886027. IF:(Q/D).
01/10/2023 The Interventions and Challenges of Antimicrobial Stewardship in the Emergency Department
Ruiz-Ramos, J, Escolà-Vergé, L, Monje-López, AE, Herrera-Mateo, S, Rivera, A. The Interventions and Challenges of Antimicrobial Stewardship in the Emergency Department. Antibiotics-Basel. 2023; 12(10)DOI:10.3390/antibiotics12101522. PMID:37887223. IF:4.300(Q1/2D).